News

age-related macular degeneration
Study finds link between macular degeneration and rheumatoid arthritis risk
Patients with age-related macular degeneration (AMD) are much more likely to develop rheumatoid arthritis (RA) according to a study published in Scientific Reports.

age-related macular degeneration
Overproduction of a protein may hold the key to a cure for AMD
Researchers recently discovered a protein that seems to play a critical role in the onset of age-related macular degeneration (AMD).

age related macular degeneration
Iris freckles may be a biomarker for age-related macular degeneration
A recent study published in the International Journal of Retina and Vitreous sheds light on the potential link between iris freckles and age-related macular degeneration (AMD).

AMD
Study finds that AREDS 2 supplementation helps slow progression of late-stage macular degeneration
While researchers have known that AREDS 2 supplements help slow the progression of AMD from the intermediate stage to the late stage, they wanted to establish whether supplementation could impact t...

age-related macular degeneration
Retrospective study suggests melatonin may decrease risk development of macular degeneration
Melatonin has antioxidant properties and researchers sought to discover if it might provide benefits for eye health.

age-related macular degeneration
Low-dose aspirin offers no benefit against macular degeneration
Australian researchers recently published the results of a study that examined the effects of low-dose aspirin on age-related macular degeneration.

age-related macular degeneration
Study shines light on Saffron's positive affects on vision
Despite it's hefty price tag, saffron, which is a powerful antioxidant, is a popular dietary supplement used for a wide range of ailments including the improvement of cognitive function, mood boost...

age related macular degeneration
Visual hallucinations commonly associated with age-related macular degeneration
Charles Bonnet Syndrome (CBS) is a condition that occurs when people lose some or all of their vision.

AMD
FDA approves Izervay for treatment of geographic atrophy
The Food and Drug Administration (FDA) recently announced their approval of Izervay for treatment of geographic atrophy (GA) secondary to age-related macular degeneration.
